Bausch + Lomb Corporation, a leading name in the eye health industry, is headquartered in California and operates extensively across North America, Europe, and Asia. Founded in 1853, the company has a rich history marked by significant milestones, including pioneering advancements in contact lenses and ocular pharmaceuticals. Specialising in a diverse range of products, Bausch + Lomb offers innovative solutions such as contact lenses, lens care products, and surgical devices. Their commitment to quality and innovation sets them apart in a competitive market. With a strong market position, the company is recognised for its dedication to improving vision and eye health, making it a trusted choice for both consumers and healthcare professionals alike.
How does Bausch + Lomb Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bausch + Lomb Corporation's score of 22 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Bausch + Lomb Corporation reported total carbon emissions of approximately 51,517,000 kg CO2e for Scope 1 and about 67,484,000 kg CO2e for Scope 2. This reflects a slight increase in emissions from 2023, where Scope 1 emissions were about 50,108,000 kg CO2e and Scope 2 emissions were approximately 64,298,000 kg CO2e. In 2022, the company recorded Scope 1 emissions of around 47,810,000 kg CO2e and Scope 2 emissions of about 51,703,000 kg CO2e. Bausch + Lomb has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. The company does not currently have specific reduction targets or initiatives listed, nor does it appear to be part of the Science Based Targets initiative (SBTi) or other formal climate pledges. As a current subsidiary of Bausch Health Companies Inc., Bausch + Lomb's emissions data and climate commitments may be influenced by the broader corporate strategies of its parent company. The absence of specific reduction targets suggests that Bausch + Lomb may need to enhance its climate strategy to align with industry standards and stakeholder expectations.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 47,810,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 51,703,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bausch + Lomb Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.